Mononuclear Nonheme Iron(IV)-Oxo Complexes
ligands have been synthesized and characterized with various
spectroscopic techniques including X-ray crystallography.
capable of oxygenating a pendent aromatic ring on the
ligand. The authors have provided mechanistic evidence that
3-5
9
The synthetic nonheme iron(IV)-oxo complexes have shown
reactivities in a variety of oxidation reactions, including
metal-centered electrophilic oxidants, presumably mono-
nuclear nonheme iron(IV)-oxo intermediates, are involved
in the arene hydroxylations, but direct evidence for the
participation of such intermediates in the catalytic cycles has
yet to be reported. More recently, Rybak-Akimova, Nam,
and their co-workers demonstrated independently that inter-
mediates generated in the reactions of mononuclear nonheme
alkane hydroxylation, olefin epoxidation, and the oxidation
of PPh
3
, sulfides, and alcohols.4
,5
Aromatic hydroxylation is an important chemical process
mediated by many metalloenzymes, including cytochromes
6
,7
P450 and nonheme iron mono- and dioxygenases. In
mononuclear nonheme iron enzymes, aromatic amino acid
hydroxylases, such as phenylalanine, tyrosine, and tryptophan
hydroxylases, catalyze the aromatic hydroxylation of the
namesake amino acids, concomitant with the two-electron
oxidation of the requisite organic cofactor tetrahydropterin
iron(II) complexes and oxidants such as H
2 2
O and m-
chloroperbenzoic acid hydroxylate benzoic acids to the
1
1,12
corresponding salicylic acids efficiently.
However, the
nature of active oxidizing intermediates and mechanisms for
the aromatic ring hydroxylations were not clearly understood
in the studies. Therefore, we deemed it timely to do a
combined experimental and theoretical study into the mech-
anisms of aromatic hydroxylation by nonheme iron-oxo
biomimetics. Since the aromatic hydroxylation reactions
reported so far have been investigated mainly under catalytic
conditions, we have performed mechanistic studies of the
aromatic ring hydroxylation with in situ-generated mono-
nuclear nonheme iron(IV)-oxo complexes. To support the
experimentally obtained conclusions we conducted density
functional theory (DFT) calculations on the hydroxylation
of benzene by a nonheme iron(IV)-oxo intermediate for the
first time. These experimental and theoretical results have
been discussed in the light of elucidating mechanisms of the
aromatic ring hydroxylation by mononuclear nonheme iron-
(IV)-oxo complexes.
8
to its quinonoid dihydropterin form. A mechanism was
proposed in which iron(IV)-oxo intermediates are involved
as active oxidants in the hydroxylation of aromatic rings,
although such iron(IV)-oxo species have not yet been
experimentally observed in the catalytic cycles of the
enzymes. In biomimetic studies, the catalytic hydroxylation
of aromatic compounds by nonheme iron(II) complexes has
been demonstrated in a number of cases.9 Notably, Que
and co-workers have shown that mononuclear nonheme iron-
,10
(II) complexes in combination with alkyl hydroperoxides are
(
4) (a) Rohde, J.-U.; In, J.-H.; Lim, M. H.; Brennessel, W. W.; Bukowski,
M. R.; Stubna, A.; M u¨ nck, E.; Nam, W.; Que, L., Jr. Science 2003,
2
99, 1037-1039. (b) Lim, M. H.; Rohde, J.-U.; Stubna, A.; Bukowski,
M. R.; Costas, M.; Ho, R. Y. N.; M u¨ nck, E.; Nam, W.; Que, L., Jr.
Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3665-3670. (c) Kaizer, J.;
Klinker, E. J.; Oh, N. Y.; Rohde, J.-U.; Song, W. J.; Stubna, A.; Kim,
J.; M u¨ nck, E.; Nam, W.; Que, L., Jr. J. Am. Chem. Soc. 2004, 126,
4
72-473. (d) Kim, S. O.; Sastri, C. V.; Seo, M. S.; Kim, J.; Nam, W.
Results and Discussion
J. Am. Chem. Soc. 2005, 127, 4178-4179. (e) Oh, N. Y.; Suh, Y.;
Park, M. J.; Seo, M. S.; Kim, J.; Nam, W. Angew. Chem., Int. Ed.
Reactivities of Nonheme Iron(IV)-Oxo Complexes in
Aromatic Hydroxylation. The mononuclear nonheme iron-
(IV)-oxo complexes, [Fe (Bn-tpen)(O)] (1) (Bn-tpen )
N-benzyl-N,N′,N′-tris(2-pyridylmethyl)ethane-1,2-diamine)
2
005, 44, 4235-4239. (f) Sastri, C. V.; Park, M. J.; Ohta, T.; Jackson,
T. A.; Stubna, A.; Seo, M. S.; Lee, J.; Kim, J.; Kitagawa, T.; M u¨ nck,
IV
2+
E.; Que, L., Jr.; Nam, W. J. Am. Chem. Soc. 2005, 127, 12494-12495.
(g) Bukowski, M. R.; Koehntop, K. D.; Stubna, A.; Bominaar, E. L.;
Halfen, J. A.; M u¨ nck, E.; Nam, W.; Que, L., Jr. Science 2005, 310,
000-1002. (h) Klinker, E. J.; Kaizer, J.; Brennessel, W. W.;
Woodrum, N. L.; Cramer, C. J.; Que, L., Jr. Angew. Chem., Int. Ed.
005, 44, 3690-3694. (i) Sastri, C. V.; Oh, K.; Lee, Y. J.; Seo, M.
S.; Shin, W.; Nam, W. Angew. Chem., Int. Ed. 2006, 45, 3992-3995.
j) Park, M. J.; Lee, J.; Suh, Y.; Kim, J.; Nam, W. J. Am. Chem. Soc.
006, 128, 2630-2634.
IV
2+
1
and [Fe (N4Py)(O)] (2) (N4Py ) N,N-bis(2-pyridyl-
methyl)-N-bis(2-pyridyl)methylamine), used in this work are
2
4
c
shown in Figure 1. The reactive species were prepared by
treating their corresponding iron(II) complexes, Fe(Bn-tpen)-
(
2
(
CF
zene (PhIO) in a solvent mixture of CH
) at 25 °C. Upon addition of anthracene to the solutions,
3
SO
3
)
2
and Fe(N4Py)(CF
3
SO
3
)
2
, with solid iodosylben-
(
5) (a) Grapperhaus, C. A.; Mienert, B.; Bill, E.; Weyherm u¨ ller, T.;
Wieghardt, K. Inorg. Chem. 2000, 39, 5306-5317. (b) Balland, V.;
Charlot, M.-F.; Banse, F.; Girerd, J.-J.; Mattioli, T. A.; Bill, E.; Bartoli,
J.-F.; Battioni, P.; Mansuy, D. Eur. J. Inorg. Chem. 2004, 301-308.
3
CN and CH Cl (1:
2
2
13
1
the intermediates reverted to the starting iron(II) complexes
with a clear isosbestic point at 490 nm for 1 and 538 nm for
(
c) Martinho, M.; Banse, F.; Bartoli, J.-F.; Mattioli, T. A.; Battioni,
P.; Horner, O.; Bourcier, S.; Girerd, J.-J. Inorg. Chem. 2005, 44, 9592-
596.
9
2
and showed pseudo-first-order decay as monitored by a
(
6) (a) Sono, M.; Roach, M. P.; Coulter, E. D.; Dawson, J. H. Chem.
ReV. 1996, 96, 2841-2887. (b) Meunier, B. In Biomimetic Oxidations
Catalyzed by Transition Metal Complexes; Meunier, B., Ed.; Imperial
College Press: London, 2000; pp 171-214. (c) Meunier, B.; de Visser,
S. P.; Shaik, S. Chem. ReV. 2004, 104, 3947-3980. (d) Cytochrome
P450: Structure, Mechanism, and Biochemistry, 3rd ed.; Ortiz de
Montellano, P. R., Ed.; Kluwer Academic/Plenum Publishers: New
York, 2005. (e) Shaik, S.; Kumar, D.; de Visser, S. P.; Altun, A.;
Thiel, W. Chem. ReV. 2005, 105, 2279-2328.
(10) (a) Kitajima, N.; Ito, M.; Fukui, H.; Moro-oka, Y. J. Am. Chem. Soc.
1993, 115, 9335-9336. (b) Funabiki, T.; Yokomizo, T.; Suzuki, S.;
Yoshida, S. Chem. Commun. 1997, 151-152. (c) Menage, S.; Galey,
J.-B.; Dumats, J.; Hussler, G.; Seite, M.; Luneau, I. G.; Chottard, G.;
Fontecave, M. J. Am. Chem. Soc. 1998, 120, 13370-13382. (d)
Mekmouche, Y.; Menage, S.; Toia-Duboc, C.; Fontecave, M.; Galey,
J.-B.; Lebrun, C.; Pecaut, J. Angew. Chem., Int. Ed. 2001, 40, 949-
952. (e) Mehn, M. P.; Fujisawa, K.; Hegg, E. L.; Que, L., Jr. J. Am.
Chem. Soc. 2003, 125, 7828-7842. (f) Avenier, F.; Dubois, L.; Latour,
J.-M. New. J. Chem. 2004, 28, 782-784.
(
7) (a) Solomon, E. I.; Brunold, T. C.; Davis, M. I.; Kemsley, J. N.; Lee,
S.-K.; Lehnert, N.; Neese, F.; Skulan, A. J.; Yang, Y.-S.; Zhou, J.
Chem. ReV. 2000, 100, 235-349. (b) Costas, M.; Mehn, M. P.; Jensen,
M. P.; Que, L., Jr. Chem. ReV. 2004, 104, 939-986.
(11) Taktak, S.; Flook, M.; Foxman, B. M.; Que, L., Jr.; Rybak-Akimova,
E. V. Chem. Commun. 2005, 5301-5303.
(
8) (a) Flatmark, T.; Stevens, R. C. Chem. ReV. 1999, 99, 2137-2160.
(
b) Klinman, J. P. J. Biol. Inorg. Chem. 2001, 6, 1-13. (c) Fitzpatrick,
(12) Oh, N. Y.; Seo, M. S.; Lim, M. H.; Consugar, M. B.; Park, M. J.;
Rohde, J.-U.; Han, J.; Kim, K. M.; Kim, J.; Que, L., Jr.; Nam, W.
Chem. Commun. 2005, 5644-5646.
P. F. Biochemistry 2003, 42, 14083-14091.
(
9) (a) Lange, S. J.; Miyake, H.; Que, L., Jr. J. Am. Chem. Soc. 1999,
1
21, 6330-6331. (b) Jensen, M. P.; Lange, S. J.; Mehn, M. P.; Que,
(13) The intermediates, 1 and 2, do not react with benzene and naphthalene
due to the low reactivity of the nonheme iron(IV)-oxo species.
E. L.; Que, L., Jr. J. Am. Chem. Soc. 2003, 125, 2113-2128.
Inorganic Chemistry, Vol. 46, No. 11, 2007 4633